Moderna · 4 hours ago
Director, Cancer Vaccines Research
Cambridge, MA
Full-time
Onsite
Director/Executive
$167K/yr - $301K/yr
9+ years expModerna is seeking a strategic and experienced Director to join their Cancer Vaccines Research team, leading critical mechanistic research in support of clinical-stage therapeutic cancer vaccines. The role focuses on utilizing mRNA platform technologies to engage anti-tumor immunity and requires collaboration with various departments to guide the scientific strategy of their clinical portfolio.
BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
No H1B
U.S. Citizen Only
Responsibilities
Design and lead in vitro and preclinical studies to investigate mechanistic questions critical to the performance of clinical-stage cancer vaccines
Define and execute experimental strategies to explore immune activation, antigen presentation, and tumor-immune interactions
Lead the development of data packages and scientific rationale that support global regulatory filings, amendments, and responses, in partnership with Regulatory colleagues
Inspire and develop a highly talented team of scientists by fostering an environment that encourages scientific rigor, intellectual autonomy, and career growth
Build strong cross-functional partnerships across Research, Clinical Development, CMC, and Regulatory to advance goals efficiently and robustly
Represent Moderna at key internal forums, contributing to thought leadership in immuno-oncology and therapeutic cancer vaccine research
Qualification
Required
PhD or MD/PhD in immunology, tumor immunology, or a closely related field
9+ years of industry or applied research experience in immuno-oncology, with demonstrated leadership in mechanistic research
Deep expertise in the biology of immune activation, T cell function, antigen processing and presentation, and tumor-immune interface
Proven ability to design and execute in vitro and preclinical studies that inform clinical-stage therapeutic development
Demonstrated ability to lead complex, cross-functional scientific initiatives with multiple stakeholders and tight timelines
Direct experience supporting regulatory filings (e.g., INDs, briefing books, HA responses), including scientific authorship and strategy development
Track record of integrating mechanistic insights into development-stage decision-making
Demonstrated success in leading and high-performing teams while fostering both scientific excellence and leadership development
A leadership style rooted in empowerment, high expectations, and collaborative mentorship
Excellent communication skills, with the ability to distill complex mechanistic findings for cross-functional and external stakeholders
A drive to contribute meaningfully to the development of transformative precision immunotherapies for patients
Preferred
Expertise developing mRNA-LNP therapeutics, including cancer vaccines, is highly desirable
Benefits
Best-in-class healthcare coverage, plus voluntary benefit programs to support your unique needs
A holistic approach to well-being, with access to fitness, mindfulness, and mental health support
Family planning benefits, including fertility, adoption, and surrogacy support
Generous paid time off, including vacation, volunteer days, sabbatical, global recharge days, and a discretionary year-end shutdown
Savings and investment opportunities to help you plan for the future
Location-specific perks and extras
Company
Moderna
Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$4.56BKey Investors
Coalition for Epidemic Preparedness InnovationsAres ManagementU.S. Department of Health & Human Services
2025-12-18Grant· $54.3M
2025-11-20Post Ipo Debt· $600M
2024-07-02Grant· $176M
Leadership Team
Stephane Bancel
Founding CEO
Kenneth Chien
Co-Founder
Recent News
2025-12-30
The Motley Fool
2025-12-27
2025-12-22
Company data provided by crunchbase